FDA Approved: RISPERIDONE — Supplemental Application (Janssen Pharmaceutical, Inc.)

View source ↗

Summary

The FDA approved Janssen's supplemental application for risperidone, resulting in changes to its labeling/indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder
• Bipolar Disorder
• Schizophrenia

Drugs mentioned

• Risperdal (risperidone)

Snippet

SUPPL AP for RISPERIDONE (RISPERIDONE)